Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
177Lu-PNT2002 in PSMA-Positive Adenoid Cystic Carcinoma
NCT06322576Phase 2Terminated
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Feb 2025
- Primary completion
- Nov 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of Lu-PNT2002 in adenoid cystic carcinoma (ACC), sponsored by Sidney Kimmel Comprehensive Cancer Center. Started Feb 2025; status: terminated.
02
Drugs
Lu-PNT2002
03
Conditions
adenoid cystic carcinoma (ACC)
Beyond the preview
Go deeper on NCT06322576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06322576.